Skip to Content

NFRMC recognized for excellence with ACC Transcatheter Valve Certification

The American College of Cardiology (ACC) has recognized The Structural Heart Program at North Florida Regional Medical Center (NFRMC) for its demonstrated expertise and commitment in treating patients receiving transcatheter valve replacement procedures.

June 24, 2020
Certified American College of Cardiology - Transcatheter Valve
The American College of Cardiology (ACC) has recognized The Structural Heart Program at North Florida Regional Medical Center (NFRMC) for its demonstrated expertise and commitment in treating patients receiving transcatheter valve replacement procedures.

Gainesville, FL — The American College of Cardiology (ACC) has recognized The Structural Heart Program at North Florida Regional Medical Center (NFRMC) for its demonstrated expertise and commitment in treating patients receiving transcatheter valve replacement procedures. NFRMC was awarded the Transcatheter Valve Certification in June 2020, based on the ACC's evaluation of the staff's ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance.

The ACC's Transcatheter Valve Certification is an external review and certification process that pairs with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification.

"NFRMC has demonstrated its commitment to providing the North Central Florida community with excellent heart care," said Phillip D. Levy, MD, FACC, chair of the ACC Accreditation Management Board. "ACC Accreditation Services is proud to award NFRMC with Transcatheter Valve Certification."

The certification uses established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance metrics to better identify opportunities for improvement.

"We are so proud and appreciative of this recognition by the ACC," said Dr. Charles Klodell, a cardiothoracic surgeon at the Florida Heart and Lung Institute. "To be the first Structural Heart program in the state of Florida and only the 7th program in the United States to achieve this designation speaks to the rigor of standards required and the magnitude of this honor. We will continue to uphold the highest standards and deliver excellent care to the patients both from our community and abroad that seek care here at North Florida Regional Medical Center."

The Structural Heart Program at NFRMC, to include the Florida Heart and Lung Institute (FHLI) and The Cardiac and Vascular Institute (TCAVI), is proud to have top quality metrics of exceptionally low mortality and morbidity, stroke, Acute Kidney Injury (AKI) rates and discharge time that place the program as one of the top in the country.

The ACC offers U.S. and international hospitals like NFRMC access to a comprehensive suite cardiac accreditation services designed to optimize patient outcomes and improve hospital financial performance. These services are focused on all aspects of cardiac care, including transcatheter valve therapies.

For more information on the Florida Heart and Lung Institute practice or to schedule an appointment, please call (352) 333-5610 or visit Florida Heart and Lung Institute.

Published:
June 24, 2020
Location:
Florida Heart & Lung Institute, HCA Florida North Florida Hospital

Related Newsroom Articles


NFRMC implants transcatheter mitral valve repair device as part of trial 

August 25, 2020
The Florida Structural Heart Disease Center at North Florida Regional Medical Center (NFRMC) together with The Florida Heart & Lung Institute (FHLI) and The Cardiac & Vascular Institute Research Foundation (TCAVIRF), have announced that they are the first in the state of Florida to implant the Edwards Lifesciences PASCAL CLASP IID/IIF device as a part of the Edwards Lifesciences PASCAL CLASP IID/IIF Pivotal Clinical Trial.

NFRMC implants transcatheter mitral valve repair device as part of trial 

August 25, 2020
The Florida Structural Heart Disease Center at North Florida Regional Medical Center (NFRMC) together with The Florida Heart & Lung Institute (FHLI) and The Cardiac & Vascular Institute Research Foundation (TCAVIRF), have announced that they are the first in the state of Florida to implant the Edwards Lifesciences PASCAL CLASP IID/IIF device as a part of the Edwards Lifesciences PASCAL CLASP IID/IIF Pivotal Clinical Trial.